Nuriye Ezgi Bektur Aykanat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nuriye Ezgi Bektur Aykanat has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Sedat Kacar
Department of Histology and Embryology, Faculty of Medicine Eskisehir Osmangazi University Eskisehir Turkey
6 shared publications - Varol Sahinturk
Department of Histology and Embryology, Eskisehir Osmangazi University, Faculty of Medicine, Eskisehir, Turkey
4 shared publications - Erhan Sahin
Department of Histology and Embryology, Faculty of Medicine, Bilecik Şeyh Edebali University, 11230 Bilecik, Türkiye., Turkey (Türkiye)
2 shared publications - Mete Ozkurt
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Nilufer Erkasap
ESKİŞEHİR OSMANGAZİ ÜNİVERSİTESİ, TIP FAKÜLTESİ
2 shared publications - Rıdvan Bağci
ADANA ŞEHİR EĞİTİM VE ARAŞTIRMA HASTANESİ
2 shared publications
Latest Publications
- 11 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 743
Ferroptosis–inflammasome crosstalk contributes to hyperglycemia-induced neuronal injury and is modulated by the ferroptosis inhibitor UAMC-3203
Background Hyperglycemia associated with diabetes and its neurological complications is strongly linked to oxidative stress and chronic inflammation; however, the contribution of ferroptosis to this process remains incompletely understood. Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation and glutathione depletion and has recently been implicated in neurodegenerative disorders and diabetic neuropathy. Nevertheless, the interaction between ferroptosis and inflammasome signaling in hyperglycemia-induced neuronal injury remains unclear. This study aimed to investigate the role of ferroptosis in hyperglycemia-induced neuronal damage and to evaluate the potential protective effects of the ferroptosis inhibitor UAMC-3203. Methods SH-SY5Y cells differentiated with retinoic acid were exposed to normoglycemic or hyperglycemic conditions and treated with UAMC-3203. Expression levels of ferroptosis-related proteins (GPX4, ACSL4), inflammatory mediators (NLRP3, Caspase-1), and the antioxidant transcription factor Nrf2 were analyzed by Western blotting. Lipid peroxidation and antioxidant status were assessed by measuring malondialdehyde (MDA) and glutathione (GSH), while apoptosis was evaluated using Annexin V/PI flow cytometry. Results Hyperglycemia suppressed GPX4 expression while increasing ACSL4, lipid peroxidation, and NLRP3 inflammasome activation, indicating enhanced ferroptotic and inflammatory stress. UAMC-3203 reduced lipid peroxidation, restored GSH levels, and markedly suppressed NLRP3 expression, particularly at higher concentrations. However, high-dose UAMC-3203 increased apoptotic cell death, suggesting a shift toward alternative cell death pathways when ferroptosis is inhibited. Conclusions Collectively, these findings indicate that hyperglycemia induces neuronal injury through a ferroptosis-associated inflammatory signaling axis and that targeting ferroptosis may represent a promising therapeutic strategy for diabetes-related neuronal damage.
- 11 May 2026
- Published by Springer Nature in Molecular Biology Reports
- Vol. 53 (1) , 743
Ferroptosis–inflammasome crosstalk contributes to hyperglycemia-induced neuronal injury and is modulated by the ferroptosis inhibitor UAMC-3203
Background Hyperglycemia associated with diabetes and its neurological complications is strongly linked to oxidative stress and chronic inflammation; however, the contribution of ferroptosis to this process remains incompletely understood. Ferroptosis is an iron-dependent form of regulated cell death characterized by lipid peroxidation and glutathione depletion and has recently been implicated in neurodegenerative disorders and diabetic neuropathy. Nevertheless, the interaction between ferroptosis and inflammasome signaling in hyperglycemia-induced neuronal injury remains unclear. This study aimed to investigate the role of ferroptosis in hyperglycemia-induced neuronal damage and to evaluate the potential protective effects of the ferroptosis inhibitor UAMC-3203. Methods SH-SY5Y cells differentiated with retinoic acid were exposed to normoglycemic or hyperglycemic conditions and treated with UAMC-3203. Expression levels of ferroptosis-related proteins (GPX4, ACSL4), inflammatory mediators (NLRP3, Caspase-1), and the antioxidant transcription factor Nrf2 were analyzed by Western blotting. Lipid peroxidation and antioxidant status were assessed by measuring malondialdehyde (MDA) and glutathione (GSH), while apoptosis was evaluated using Annexin V/PI flow cytometry. Results Hyperglycemia suppressed GPX4 expression while increasing ACSL4, lipid peroxidation, and NLRP3 inflammasome activation, indicating enhanced ferroptotic and inflammatory stress. UAMC-3203 reduced lipid peroxidation, restored GSH levels, and markedly suppressed NLRP3 expression, particularly at higher concentrations. However, high-dose UAMC-3203 increased apoptotic cell death, suggesting a shift toward alternative cell death pathways when ferroptosis is inhibited. Conclusions Collectively, these findings indicate that hyperglycemia induces neuronal injury through a ferroptosis-associated inflammatory signaling axis and that targeting ferroptosis may represent a promising therapeutic strategy for diabetes-related neuronal damage.
- Open Access
- 3 June 2022
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 20 (2) , 79-85
Investigation of the Anti-inflammatory Effects of Astaxanthin on Liver Tissue in Lipopolysaccharide-induced Sepsis in Rats
Amaç: Kortikosteroidler enflamasyonu önlemek için sepsiste kullanılan tedavi yöntemlerinden biridir. Çalışmamızda astaksantinin sepsiste anti-enflamatuvar aktivitesini göstermeyi ve deksametazon ile karşılaştırmayı amaçladık. Gereç ve Yöntem: Yerel etik komitenin onayından sonra, 40 Sprague-Dawley erkek sıçan randomize olarak kontrol grubu (n=8), lipopolisakkarit grubu (n=8), astaksantin grubu (n=8), astaksantin + lipopolisakkarit grubu (n=8) ve deksametazon + lipopolisakkarit grubu (n=8) olarak belirlendi. İlk gün bu gruplara sırasıyla dimetil sülfoksit, Salmonella typhimurium lipopolisakkariti, dimetil sülfoksit içinde çözünmüş astaksantin, astaksantin ve lipopolisakkarit ve deksametazon verildi. Yirmi dördüncü saatin sonunda sıçanlara laparotomi yapılarak karaciğer ve kan örnekleri alındı. İstatistiksel analiz için GraphPad Prism6 programı kullanıldı. 0,05’ten küçük p değerleri anlamlı kabul edildi. Bulgular: Lipopolisakkarit grubu ile karşılaştırıldığında, her iki tedavi grubunda da nükleer faktör-kappa B seviyelerinde istatistiksel olarak anlamlı bir düşüş vardı. Tedavi gruplarında lipopolisakkarit grubuna göre apoptotik hücreler ve reaksiyon şiddeti anlamlı olarak azaldı. Sonuç: Astaksantin kullanımının, karaciğer dokusunda sepsis tedavisi konusunda olumlu bir etkisi olduğunu bulduk. Farklılıklar olmasına rağmen, deksametazon uygulamasına kıyasla benzer ölçüm değerleri elde edildi.
- 3 June 2022
- Published by Turkish Society of Intensive Care in Turkish Journal of Intensive Care
- Vol. 20 (2) , 79-85
Open AccessInvestigation of the Anti-inflammatory Effects of Astaxanthin on Liver Tissue in Lipopolysaccharide-induced Sepsis in Rats
Amaç: Kortikosteroidler enflamasyonu önlemek için sepsiste kullanılan tedavi yöntemlerinden biridir. Çalışmamızda astaksantinin sepsiste anti-enflamatuvar aktivitesini göstermeyi ve deksametazon ile karşılaştırmayı amaçladık. Gereç ve Yöntem: Yerel etik komitenin onayından sonra, 40 Sprague-Dawley erkek sıçan randomize olarak kontrol grubu (n=8), lipopolisakkarit grubu (n=8), astaksantin grubu (n=8), astaksantin + lipopolisakkarit grubu (n=8) ve deksametazon + lipopolisakkarit grubu (n=8) olarak belirlendi. İlk gün bu gruplara sırasıyla dimetil sülfoksit, Salmonella typhimurium lipopolisakkariti, dimetil sülfoksit içinde çözünmüş astaksantin, astaksantin ve lipopolisakkarit ve deksametazon verildi. Yirmi dördüncü saatin sonunda sıçanlara laparotomi yapılarak karaciğer ve kan örnekleri alındı. İstatistiksel analiz için GraphPad Prism6 programı kullanıldı. 0,05’ten küçük p değerleri anlamlı kabul edildi. Bulgular: Lipopolisakkarit grubu ile karşılaştırıldığında, her iki tedavi grubunda da nükleer faktör-kappa B seviyelerinde istatistiksel olarak anlamlı bir düşüş vardı. Tedavi gruplarında lipopolisakkarit grubuna göre apoptotik hücreler ve reaksiyon şiddeti anlamlı olarak azaldı. Sonuç: Astaksantin kullanımının, karaciğer dokusunda sepsis tedavisi konusunda olumlu bir etkisi olduğunu bulduk. Farklılıklar olmasına rağmen, deksametazon uygulamasına kıyasla benzer ölçüm değerleri elde edildi.
- 1 December 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (3) , 327-334
Silymarin Inhibited A549 Cells by Activating SLIT2 Protein and Suppressing Expression of CXCR4
Akciğer kanseri, dünya çapında hem erkeklerde hem de kadınlarda kansere bağlı önde gelen ölüm nedenlerindendir. SLIT2/ROBO1 sinyali, çeşitli kanser tiplerini inhibe ettiği bildirilen çok önemli bir yolaktır. CXCR4, kanser ilerlemesinde rol oynayan bir kemokin reseptörüdür. Silimarin, başta karaciğer hastalıkları olmak üzere akciğer kanseri de dahil çeşitli kanserlerde anti-kanserojen aktivitesi öne sürülen bir fitokimyasaldır. Ancak silimarinin akciğer kanserinde SLIT2–ROBO1–CXCR4 ekseni üzerindeki etkisini inceleyen çalışma bulunmamaktadır. Burada amacımız silimarinin A549 hücreleri üzerindeki sitotoksik ve morfolojik etkilerini araştırmak ve SLIT2-ROBO1-CXCR4 yolağındaki rolünü ortaya çıkarmaktır. İlk olarak, silimarinin doz analizi için 24, 48 ve 72 saat uzunluğunda sitotoksisite testleri yapıldı. Ardından değişen dozlarda silimarin ile morfolojik değerlendirme için hücreler H-E ile boyandı. Daha sonra SLIT2, ROBO1 ve CXCR4 proteinleri için western blot ve immünositokimya analizleri yapıldı. MTT analizine göre, A549 hücrelerine karşı silimarinin IC50 konsantrasyonları 24, 48 ve 72 saatlik uygulamaları için sırasıyla 930.1, 432.1 ve 99.8 μM olarak saptandı. H-E boyama yapılarak morfolojik olarak incelendiğinde sitoplazmik vakuoller, küçülmüş heterokromatin çekirdek ve bazofilik sitoplazmalı hücreler gözlendi. 750 μM silimarin ile SLIT2, ROBO1 ve CXCR4 proteinleri için Western blot ve immünositokimya analizleri yapıldı. 750 μM silimarin, kontrol grubuna kıyasla SLIT2 ve ROBO1 ekspresyonlarını arttırırken CXCR4'ü azalttı. Sonuç olarak silimarin, SLIT2 ve ROBO1 protein ekspresyonunu aktive ederek ve CXCR4 ekspresyonunu inhibe ederek A549 hücrelerini doza bağlı olarak inhibe etmiştir. Silimarinin akciğer kanseri üzerindeki etkileri literatürde belirtilmiştir. Ancak bu çalışma, A549 hücrelerinde SLIT2–ROBO1–CXCR4 proteinleri ile silimarin arasındaki etkileşimi inceleyen ilk çalışmadır. Çalışmamızın bundan sonraki araştırmalara yeni ufuklar açacağına inanıyoruz.
- 1 December 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (3) , 327-334
Silymarin Inhibited A549 Cells by Activating SLIT2 Protein and Suppressing Expression of CXCR4
Akciğer kanseri, dünya çapında hem erkeklerde hem de kadınlarda kansere bağlı önde gelen ölüm nedenlerindendir. SLIT2/ROBO1 sinyali, çeşitli kanser tiplerini inhibe ettiği bildirilen çok önemli bir yolaktır. CXCR4, kanser ilerlemesinde rol oynayan bir kemokin reseptörüdür. Silimarin, başta karaciğer hastalıkları olmak üzere akciğer kanseri de dahil çeşitli kanserlerde anti-kanserojen aktivitesi öne sürülen bir fitokimyasaldır. Ancak silimarinin akciğer kanserinde SLIT2–ROBO1–CXCR4 ekseni üzerindeki etkisini inceleyen çalışma bulunmamaktadır. Burada amacımız silimarinin A549 hücreleri üzerindeki sitotoksik ve morfolojik etkilerini araştırmak ve SLIT2-ROBO1-CXCR4 yolağındaki rolünü ortaya çıkarmaktır. İlk olarak, silimarinin doz analizi için 24, 48 ve 72 saat uzunluğunda sitotoksisite testleri yapıldı. Ardından değişen dozlarda silimarin ile morfolojik değerlendirme için hücreler H-E ile boyandı. Daha sonra SLIT2, ROBO1 ve CXCR4 proteinleri için western blot ve immünositokimya analizleri yapıldı. MTT analizine göre, A549 hücrelerine karşı silimarinin IC50 konsantrasyonları 24, 48 ve 72 saatlik uygulamaları için sırasıyla 930.1, 432.1 ve 99.8 μM olarak saptandı. H-E boyama yapılarak morfolojik olarak incelendiğinde sitoplazmik vakuoller, küçülmüş heterokromatin çekirdek ve bazofilik sitoplazmalı hücreler gözlendi. 750 μM silimarin ile SLIT2, ROBO1 ve CXCR4 proteinleri için Western blot ve immünositokimya analizleri yapıldı. 750 μM silimarin, kontrol grubuna kıyasla SLIT2 ve ROBO1 ekspresyonlarını arttırırken CXCR4'ü azalttı. Sonuç olarak silimarin, SLIT2 ve ROBO1 protein ekspresyonunu aktive ederek ve CXCR4 ekspresyonunu inhibe ederek A549 hücrelerini doza bağlı olarak inhibe etmiştir. Silimarinin akciğer kanseri üzerindeki etkileri literatürde belirtilmiştir. Ancak bu çalışma, A549 hücrelerinde SLIT2–ROBO1–CXCR4 proteinleri ile silimarin arasındaki etkileşimi inceleyen ilk çalışmadır. Çalışmamızın bundan sonraki araştırmalara yeni ufuklar açacağına inanıyoruz.
- Open Access
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2177-2184
The role of anakinra in the modulation of intestinal cell apoptosis and inflammatory response during ischemia/reperfusion
Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into four groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50mg/kg and 100mg/kg, respectively). Gene expressions of Caspase-3, TNF-?, IL-1?, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of SOD, CAT, and MDA were studied by the ELISA method and tissue samples were examined histopathologically as well. Anakinra inhibited the expression of IL-1?, IL-6, and TNF-? and decreased the SOD, CAT, and MDA caused by ischemia-reperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups as well were less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100mg/kg was found to be histopathologically more effective.
- 30 August 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (4) , 2177-2184
Open AccessThe role of anakinra in the modulation of intestinal cell apoptosis and inflammatory response during ischemia/reperfusion
Even though interleukin-1 receptor antagonist, IL-1Ra, is used in certain inflammatory diseases, its effect on ischemia-reperfusion injury is a current research topic. We aimed to investigate the protective effects of anakinra, an IL-1Ra, on the I/R induced intestinal injury. The rat model of intestinal ischemia-reperfusion was induced. Rats were randomized into four groups: (group 1) control group, (group 2) I/R group, (group 3 and 4) treatment groups (50mg/kg and 100mg/kg, respectively). Gene expressions of Caspase-3, TNF-?, IL-1?, IL-6, and apoptotic cells in tissue samples were evaluated by PCR and TUNEL methods, respectively. Plasma levels of SOD, CAT, and MDA were studied by the ELISA method and tissue samples were examined histopathologically as well. Anakinra inhibited the expression of IL-1?, IL-6, and TNF-? and decreased the SOD, CAT, and MDA caused by ischemia-reperfusion injury in both treatment groups. Caspase-3 expression and TUNEL-positive cell number in treatment groups as well were less. Histopathologically, anakinra better preserved the villous structure of the small intestine at a dose of 100 mg/kg than 50 mg/kg. Anakinra decreased the intestinal damage caused by ischemia-reperfusion and a dose of 100mg/kg was found to be histopathologically more effective.
- 1 August 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (2) , 241-245
Investigation of Dose-Dependent Effect of Curcumin on T-47D Breast Cancer Cells
Zingiberaceae familyasına ait zerdeçaldan elde edilen bir polifenol olan kurkumin, anti-inflamatuar, anti-tümör, anti-oksidatif ve antimikrobiyal etkiler dahil olmak üzere birçok etkiye sahiptir. Kurkuminin farklı kanser hücreleri üzerindeki etkileri hakkında birçok çalışma bulunmaktadır. Bu çalışma, kurkuminin T-47D meme kanseri hücre canlılığı üzerindeki anti-kanser etkisini araştırmayı amaçlamaktadır. T-47D meme kanseri hücrelerine farklı dozlarda uygulanan kurkuminin etkisi MTT yöntemi ve inverted mikroskop ile araştırılmıştır. Kurkuminin T-47D hücrelerinde IC50 dozu 24 saat sonunda 65,8 μM, 48 saat sonunda 46,4 μM ve 72 saat sonunda ise 26,6 μM olarak belirlenmiştir. Morfolojik değerlendirmede ise kurkumin uygulanmış hücreler yuvarlak ve flask yüzeyinden ayrılmış kitleler halinde gözlenmektedir. Sonuçlarımız, kurkuminin T-47D hücre proliferasyonunu önemli ölçüde azalttığını göstermektedir. Kurkumin, tek başına veya diğer moleküllerle kombinasyon halinde meme kanseri tedavisi için bir aday olabilir. Gelecekte, kurkuminin meme kanseri hücreleri üzerindeki etki mekanizmasını aydınlatmak için daha kapsamlı ve çok merkezli destekli ileri klinik çalışmalara ihtiyaç vardır.
- 1 August 2021
- Published by Uludag Universitesi Tip Fakultesi Dergisi in Uludağ Üniversitesi Tıp Fakültesi Dergisi
- Vol. 47 (2) , 241-245
Investigation of Dose-Dependent Effect of Curcumin on T-47D Breast Cancer Cells
Zingiberaceae familyasına ait zerdeçaldan elde edilen bir polifenol olan kurkumin, anti-inflamatuar, anti-tümör, anti-oksidatif ve antimikrobiyal etkiler dahil olmak üzere birçok etkiye sahiptir. Kurkuminin farklı kanser hücreleri üzerindeki etkileri hakkında birçok çalışma bulunmaktadır. Bu çalışma, kurkuminin T-47D meme kanseri hücre canlılığı üzerindeki anti-kanser etkisini araştırmayı amaçlamaktadır. T-47D meme kanseri hücrelerine farklı dozlarda uygulanan kurkuminin etkisi MTT yöntemi ve inverted mikroskop ile araştırılmıştır. Kurkuminin T-47D hücrelerinde IC50 dozu 24 saat sonunda 65,8 μM, 48 saat sonunda 46,4 μM ve 72 saat sonunda ise 26,6 μM olarak belirlenmiştir. Morfolojik değerlendirmede ise kurkumin uygulanmış hücreler yuvarlak ve flask yüzeyinden ayrılmış kitleler halinde gözlenmektedir. Sonuçlarımız, kurkuminin T-47D hücre proliferasyonunu önemli ölçüde azalttığını göstermektedir. Kurkumin, tek başına veya diğer moleküllerle kombinasyon halinde meme kanseri tedavisi için bir aday olabilir. Gelecekte, kurkuminin meme kanseri hücreleri üzerindeki etki mekanizmasını aydınlatmak için daha kapsamlı ve çok merkezli destekli ileri klinik çalışmalara ihtiyaç vardır.
- Open Access
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1553-1562
Investigation of the effect of hyperthyroidism on endoplasmic reticulum stress and tran- sient receptor potential canonical 1 channel in the kidney
Background/aim: Hyperthyroidism is associated with results in increased glomerular filtration rate as well as increased renin-angiotensin-aldosterone activation. The disturbance of Ca2+ homeostasis in the endoplasmic reticulum (ER) is associated with many diseases, including diabetic nephropathy and hyperthyroidism. Transient receptor potential canonical 1 (TRPC1) channel is the first cloned TRPC family protein. Although it is expressed in many places in the kidney, its function is uncertain. TRPC1 is involved in regulating Ca2+ homeostasis, and its upregulation increases ER Ca2+ level, activates the unfolded protein response, which leads to cellular damage in the kidney. This study investigated the role of TRPC1 in the kidneys of hyperthyroid rats in terms of ER stress markers that are glucose-regulated protein 78 (GRP78), activating transcription factor 6 (ATF6), (protein kinase R (PKR)-like endoplasmic reticulum kinase) (PERK), Inositol-requiring enzyme 1 (IRE1). Materials and methods: Twenty male rats were assigned into control and hyperthyroid groups (n = 10). Hyperthyroidism was induced by adding 12 mg/L thyroxine into the drinking water of rats for 4 weeks. The serum-free T3 and T4 (fT3, fT4), TSH, blood urea nitrogen (BUN), and creatinine levels were measured. The histochemical analysis of kidney sections for morphological changes and also immunohistochemical and western blot analysis of kidney sections were performed for GRP78, ATF6, PERK, IRE1, TRPC1 antibodies. Results: TSH, BUN, and creatinine levels decreased while fT3 and fT4 levels increased in the hyperthyroid rat. The morphologic analysis resulted in the capillary basal membrane thickening in glomeruli and also western blot, and immunohistochemical results showed an increase in TRPC1, GRP78, and ATF6 in the hyperthyroid rat (p < 0.05). Conclusion: In conclusion, in our study, we showed for the first time that the relationship between ER stress and TRPC1, and their increased expression caused renal damage in hyperthyroid rats.
- 28 June 2021
- Published by The Scientific and Technological Research Council of Turkey (TUBITAK-ULAKBIM) - DIGITAL COMMONS JOURNALS in TURKISH JOURNAL OF MEDICAL SCIENCES
- Vol. 51 (3) , 1553-1562
Open AccessInvestigation of the effect of hyperthyroidism on endoplasmic reticulum stress and tran- sient receptor potential canonical 1 channel in the kidney
Background/aim: Hyperthyroidism is associated with results in increased glomerular filtration rate as well as increased renin-angiotensin-aldosterone activation. The disturbance of Ca2+ homeostasis in the endoplasmic reticulum (ER) is associated with many diseases, including diabetic nephropathy and hyperthyroidism. Transient receptor potential canonical 1 (TRPC1) channel is the first cloned TRPC family protein. Although it is expressed in many places in the kidney, its function is uncertain. TRPC1 is involved in regulating Ca2+ homeostasis, and its upregulation increases ER Ca2+ level, activates the unfolded protein response, which leads to cellular damage in the kidney. This study investigated the role of TRPC1 in the kidneys of hyperthyroid rats in terms of ER stress markers that are glucose-regulated protein 78 (GRP78), activating transcription factor 6 (ATF6), (protein kinase R (PKR)-like endoplasmic reticulum kinase) (PERK), Inositol-requiring enzyme 1 (IRE1). Materials and methods: Twenty male rats were assigned into control and hyperthyroid groups (n = 10). Hyperthyroidism was induced by adding 12 mg/L thyroxine into the drinking water of rats for 4 weeks. The serum-free T3 and T4 (fT3, fT4), TSH, blood urea nitrogen (BUN), and creatinine levels were measured. The histochemical analysis of kidney sections for morphological changes and also immunohistochemical and western blot analysis of kidney sections were performed for GRP78, ATF6, PERK, IRE1, TRPC1 antibodies. Results: TSH, BUN, and creatinine levels decreased while fT3 and fT4 levels increased in the hyperthyroid rat. The morphologic analysis resulted in the capillary basal membrane thickening in glomeruli and also western blot, and immunohistochemical results showed an increase in TRPC1, GRP78, and ATF6 in the hyperthyroid rat (p < 0.05). Conclusion: In conclusion, in our study, we showed for the first time that the relationship between ER stress and TRPC1, and their increased expression caused renal damage in hyperthyroid rats.
- 18 March 2020
- Published by Wiley in Journal of Food Biochemistry
- Vol. 44 (6) , e13194
Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
Nonalcoholic fatty liver disease (NAFLD) is an important health problem. The prevalence of NAFLD is increasing, especially in the Western countries. Although there are several intracellular pathways in NAFLD, endoplasmic reticulum (ER) stress has recently gained importance. Silymarin is an important liver‐protective biological molecule. In light of this information, we investigated mice for the effect of silymarin on ER stress in the NAFLD model. In our study, the mice were randomly divided into six groups: Control, silymarin 100 and 200 mg/kg sham, fructose‐induced NAFLD, and NAFLD + silymarin groups. After the last administrations, liver and blood samples were taken and hematoxylin‐eosin, as well as Oil red O staining, were performed. As a result, the body and liver weights, lipid profile, AST, ALT, and glucose levels, along with the ER stress markers, increased in the NAFLD‐only group. Silymarin treatments reversed most of these changes. Particularly, 200 mg/kg silymarin was more effective. Practical applications According to the results, silymarin attenuated NAFLD by decreasing the ER stress proteins GRP78 and XBP‐1. Silymarin may be therapeutic in the treatment of NAFLD as well as other ER‐stress‐based diseases. Silymarin can also be taken with food for prophylactic purposes.
- 18 March 2020
- Published by Wiley in Journal of Food Biochemistry
- Vol. 44 (6) , e13194
Silymarin attenuated nonalcoholic fatty liver disease through the regulation of endoplasmic reticulum stress proteins GRP78 and XBP-1 in mice
Nonalcoholic fatty liver disease (NAFLD) is an important health problem. The prevalence of NAFLD is increasing, especially in the Western countries. Although there are several intracellular pathways in NAFLD, endoplasmic reticulum (ER) stress has recently gained importance. Silymarin is an important liver‐protective biological molecule. In light of this information, we investigated mice for the effect of silymarin on ER stress in the NAFLD model. In our study, the mice were randomly divided into six groups: Control, silymarin 100 and 200 mg/kg sham, fructose‐induced NAFLD, and NAFLD + silymarin groups. After the last administrations, liver and blood samples were taken and hematoxylin‐eosin, as well as Oil red O staining, were performed. As a result, the body and liver weights, lipid profile, AST, ALT, and glucose levels, along with the ER stress markers, increased in the NAFLD‐only group. Silymarin treatments reversed most of these changes. Particularly, 200 mg/kg silymarin was more effective. Practical applications According to the results, silymarin attenuated NAFLD by decreasing the ER stress proteins GRP78 and XBP‐1. Silymarin may be therapeutic in the treatment of NAFLD as well as other ER‐stress‐based diseases. Silymarin can also be taken with food for prophylactic purposes.
- 15 February 2020
- Published by Springer Nature in Medical Oncology
- Vol. 37 (3) , 18
Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4
Among other cancers, prostate cancer is globally the second most rampant one with the incidence of 29.4% among men. SLIT2/ROBO1 signaling is very crucial pathway causally implicated in many cancers and reported to inhibit a variety of cancer cell types. CXCR4 is a chemokine receptor implicated in cancer progression. Silymarin is a phytochemical, of which anti-carcinogenic activity was suggested in various cancers, including prostate cancer. However, there are no studies examining the effect of silymarin on SLIT2–Robo1–CXCR4 axis. Herein, our goal is to explore cytotoxic and morphological effects of silymarin on DU145 cells and to reveal its role in Slit2/Robo and CXCR1 pathway. First, 24, 48 and 72 h-long cytotoxicity tests were performed for dose analysis of silymarin, followed H–E stain for morphological evaluation with varying doses of silymarin. Afterward, western blot and immunocytochemistry analyses were carried out for SLIT2, ROBO1 and CXCR4 proteins. According to MTT analysis, IC50 concentrations for silymarin were 315, 126 and 70 µM against DU145 cells for 24, 48 and 72 h treatments. In H–E, several apoptotic hallmarks, including, condensed, kidney-shaped and eccentric nuclei, membrane blebbings and apoptotic body formations were observed. Silymarin increased the expressions of SLIT2 and ROBO1 while decreased CXCR4 when compared to control group in immunocytochemistry and Western blot. To summarize, silymarin inhibited DU145 cells dose-dependently by activating SLIT2 protein and inhibiting expression of CXCR4. This study is the first examining the interplay between Slit2–Robo1–CXCR4 proteins and silymarin in DU145 cells. We believe that our study will provide new insights for future studies.
- 15 February 2020
- Published by Springer Nature in Medical Oncology
- Vol. 37 (3) , 18
Silymarin inhibited DU145 cells by activating SLIT2 protein and suppressing expression of CXCR4
Among other cancers, prostate cancer is globally the second most rampant one with the incidence of 29.4% among men. SLIT2/ROBO1 signaling is very crucial pathway causally implicated in many cancers and reported to inhibit a variety of cancer cell types. CXCR4 is a chemokine receptor implicated in cancer progression. Silymarin is a phytochemical, of which anti-carcinogenic activity was suggested in various cancers, including prostate cancer. However, there are no studies examining the effect of silymarin on SLIT2–Robo1–CXCR4 axis. Herein, our goal is to explore cytotoxic and morphological effects of silymarin on DU145 cells and to reveal its role in Slit2/Robo and CXCR1 pathway. First, 24, 48 and 72 h-long cytotoxicity tests were performed for dose analysis of silymarin, followed H–E stain for morphological evaluation with varying doses of silymarin. Afterward, western blot and immunocytochemistry analyses were carried out for SLIT2, ROBO1 and CXCR4 proteins. According to MTT analysis, IC50 concentrations for silymarin were 315, 126 and 70 µM against DU145 cells for 24, 48 and 72 h treatments. In H–E, several apoptotic hallmarks, including, condensed, kidney-shaped and eccentric nuclei, membrane blebbings and apoptotic body formations were observed. Silymarin increased the expressions of SLIT2 and ROBO1 while decreased CXCR4 when compared to control group in immunocytochemistry and Western blot. To summarize, silymarin inhibited DU145 cells dose-dependently by activating SLIT2 protein and inhibiting expression of CXCR4. This study is the first examining the interplay between Slit2–Robo1–CXCR4 proteins and silymarin in DU145 cells. We believe that our study will provide new insights for future studies.
- 8 January 2020
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (1) , 199-207
Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway
Background 14 million people are diagnosed with new cancer and approximately 8 million people die from cancer every year. Hepatocellular carcinoma is the most common type of liver cancer and covers almost 5–6% of cancer deaths worldwide. Silybum marianum, a plant that contains silymarin, has been used traditionally in the treatment of liver diseases for centuries. The antioxidant, anti-inflammatory and anti-fibrotic anti-cancer properties of silymarin have been demonstrated in several studies in vivo and in vitro. The Slit/Robo signaling pathway plays a role in many processes such as neurogenesis, angiogenesis, cell proliferation, cell movement, cancer progression, cell invasion, migration and metastasis. In this study, we aimed to investigate the effects of silymarin on HepG2 Hepatocellular carcinoma cells on Slit-2/Robo-1 signaling pathway and CXCR-4 which plays a role in the metastasis process. Methods HepG2 Hepatocellular carcinoma cells were used in the study. Different doses of silymarin’s effect on HepG2 cells were observed by hematoxylin and eosin staining. Immunoblotting techniques were used to test the expression of Slit-2/Robo-1 and CXCR4 protein level. Immunocytochemistry was used to visualize the localization of Slit-2/Robo-1 and CXCR4 protein within the cells. Results Silymarin caused apoptosis in HepG2 cells, decreased the level of CXCR-4 protein dose-dependently, and decreased the Slit-2/Robo-1 protein level at low doses and increased it at high doses. Conclusions Silymarin doses showed anti-carcinogenic, anti-metastatic and apoptotic effects in a dose-dependent manner on HepG2 cells through the Slit-2/Robo-1 pathway.
- 8 January 2020
- Published by Springer Nature in Pharmacological Reports
- Vol. 72 (1) , 199-207
Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway
Background 14 million people are diagnosed with new cancer and approximately 8 million people die from cancer every year. Hepatocellular carcinoma is the most common type of liver cancer and covers almost 5–6% of cancer deaths worldwide. Silybum marianum, a plant that contains silymarin, has been used traditionally in the treatment of liver diseases for centuries. The antioxidant, anti-inflammatory and anti-fibrotic anti-cancer properties of silymarin have been demonstrated in several studies in vivo and in vitro. The Slit/Robo signaling pathway plays a role in many processes such as neurogenesis, angiogenesis, cell proliferation, cell movement, cancer progression, cell invasion, migration and metastasis. In this study, we aimed to investigate the effects of silymarin on HepG2 Hepatocellular carcinoma cells on Slit-2/Robo-1 signaling pathway and CXCR-4 which plays a role in the metastasis process. Methods HepG2 Hepatocellular carcinoma cells were used in the study. Different doses of silymarin’s effect on HepG2 cells were observed by hematoxylin and eosin staining. Immunoblotting techniques were used to test the expression of Slit-2/Robo-1 and CXCR4 protein level. Immunocytochemistry was used to visualize the localization of Slit-2/Robo-1 and CXCR4 protein within the cells. Results Silymarin caused apoptosis in HepG2 cells, decreased the level of CXCR-4 protein dose-dependently, and decreased the Slit-2/Robo-1 protein level at low doses and increased it at high doses. Conclusions Silymarin doses showed anti-carcinogenic, anti-metastatic and apoptotic effects in a dose-dependent manner on HepG2 cells through the Slit-2/Robo-1 pathway.
- 13 February 2019
- Published by Taylor & Francis in Neurological Research
- Vol. 41 (6) , 544-553
Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion
Objectives: Neuropathic pain reduces the life qualities of patients with Diabetes mellitus. Clinical guidelines recommend relief in diabetic neuropathic pain through the use of some antidepressants, anticonvulsants, opioids as well as capsaicin cream or lidocaine patches. However, since the majority of patients do not or partially respond to current treatments, there is a growing necessity for new drugs increasing the pain relief in patients with diabetes. Therefore, based on the therapeutic potential of antidepressants on neuropathic pain, we investigated the promising antihyperalgesic effect of mirtazapine (MRT) in painful diabetic neuropathy. Methods: Experimental diabetes was induced in rats by single intraperitoneal injection of 55 mg/kg dose of streptozocin (STZ). After 4 weeks of injection of STZ, MRT was administrated for 14 days at 40 mg/kg dose. Randall–Selitto and Hargreaves tests were applied for paw-withdrawal threshold and paw-withdrawal latency measurement. TRPV1 and ASIC1 expressions measured by Western blot in dorsal root ganglion and spinal cord. Results: Administration of MRT significantly improved both of the decreased paw-withdrawal threshold and shortened the paw-withdrawal latency of diabetic rats, respectively. Besides, increased levels of TRPV1 and ASIC1 channels in dorsal root ganglion and spinal cord of diabetic rats, evaluated by Western blot method, were decreased following the MRT treatment. Discussion: These data show, for the first time, that MRT has beneficial effects against diabetes-induced hyperalgesia, and that suppressive effect of this drug on TRPV1 and ASIC1 levels, which are increased in diabetic rats, may be some of the pharmacological mechanisms underlying the exhibited antihyperalgesic effect of MRT.
- 13 February 2019
- Published by Taylor & Francis in Neurological Research
- Vol. 41 (6) , 544-553
Beneficial effect of mirtazapine on diabetes-induced hyperalgesia: involvement of TRPV1 and ASIC1 channels in the spinal cord and dorsal root ganglion
Objectives: Neuropathic pain reduces the life qualities of patients with Diabetes mellitus. Clinical guidelines recommend relief in diabetic neuropathic pain through the use of some antidepressants, anticonvulsants, opioids as well as capsaicin cream or lidocaine patches. However, since the majority of patients do not or partially respond to current treatments, there is a growing necessity for new drugs increasing the pain relief in patients with diabetes. Therefore, based on the therapeutic potential of antidepressants on neuropathic pain, we investigated the promising antihyperalgesic effect of mirtazapine (MRT) in painful diabetic neuropathy. Methods: Experimental diabetes was induced in rats by single intraperitoneal injection of 55 mg/kg dose of streptozocin (STZ). After 4 weeks of injection of STZ, MRT was administrated for 14 days at 40 mg/kg dose. Randall–Selitto and Hargreaves tests were applied for paw-withdrawal threshold and paw-withdrawal latency measurement. TRPV1 and ASIC1 expressions measured by Western blot in dorsal root ganglion and spinal cord. Results: Administration of MRT significantly improved both of the decreased paw-withdrawal threshold and shortened the paw-withdrawal latency of diabetic rats, respectively. Besides, increased levels of TRPV1 and ASIC1 channels in dorsal root ganglion and spinal cord of diabetic rats, evaluated by Western blot method, were decreased following the MRT treatment. Discussion: These data show, for the first time, that MRT has beneficial effects against diabetes-induced hyperalgesia, and that suppressive effect of this drug on TRPV1 and ASIC1 levels, which are increased in diabetic rats, may be some of the pharmacological mechanisms underlying the exhibited antihyperalgesic effect of MRT.